The Evaluation of Ischemia Modified Albumin and Adropin Levels in Patients with Pulmonary Embolism

Background: Pulmonary embolism (PE) is a serious clinical condition and difficult to be diagnosed. The aim of the present study was evaluate serum adropin ischemia-modified albumin (IMA) levels in patients with PE. 
 Materials Methods: consisted 109 participants, including 50 PE 59 healthy individuals. diagnosed through computed tomography pulmonary angiography (CTPA) were included into study. Serum IMA concentrations measured by an enzyme-linked immunosorbent assay kit. Results: had higher (607.5±205.1 ng/mL) lower (2128.6±801.8 ng/mL), compared those controls (505.5±231.3 ng/mL 2466.9±1044.9 ng/mL, respectively); however, difference not significant. In study, we found weak negative correlation between (p=0.020, r=-0.348).
 Conclusions: our among PE, there no significant levels, although atropin concentration high, low. So, consider that both are inappropriate markers for diagnosis